I.TO : Summary for INTELLIPHARMACEUTICS INTERNATIO - Yahoo Finance

Canadian Markets closed

IntelliPharmaCeutics International Inc. (I.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
3.23+0.04 (+1.25%)
At close: 3:58PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.19
Open3.26
Bid3.15 x
Ask3.45 x
Day's Range3.15 - 3.26
52 Week Range1.78 - 4.50
Volume7,625
Avg. Volume18,162
Market Cap109.26M
BetaN/A
PE Ratio (TTM)-8.50
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected
    Zacks17 days ago

    IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected

    IntelliPharmaCeutics International Inc. (IPCI) reported loss of 7 cents per share in the first quarter of 2017, narrower than both the Zacks Consensus Estimate of a loss of 8 cents and the year-ago loss of 9 cents per share.

  • Associated Press19 days ago

    Intellipharmaceutics reports 1Q loss

    The Toronto-based company said it had a loss of 7 cents per share. The extended-release drug developer posted revenue of $1.2 million in the period. In the final minutes of trading on Tuesday, the company's ...

  • Associated Press19 days ago

    Intellipharmaceutics reports 1Q loss

    The Toronto-based company said it had a loss of 7 cents per share. The extended-release drug developer posted revenue of $1.2 million in the period. In the final minutes of trading on Tuesday, the company's ...